|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 121.50 GBX | -1.70% |
|
-1.93% | -2.40% |
| Feb. 20 | Inflation's Reality Check | |
| Feb. 20 | PureTech says its pulmonary fibrosis drug granted orphan designation | AN |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| -2.66x | - | 0.01x | - | -0.51x | -0.47x | - | 400M | ||
| 35.29x | 3.61x | 0.59x | 5.14x | 17.22x | 25.22x | 0.97% | 45.49B | ||
| 54.35x | 7x | 0.46x | 4.68x | 31.54x | 39.8x | -.--% | 33.41B | ||
| 56.43x | 2.69x | 0.62x | 11.55x | 32.31x | 41.49x | 0.34% | 31.32B | ||
| 21.15x | 3.8x | 4.06x | 2.46x | 10.59x | 16.05x | -.--% | 29.29B | ||
| -12.85x | 17.4x | -0.45x | 334.46x | -10.88x | -10.79x | -.--% | 19.5B | ||
| 45.29x | 167.33x | -0.2x | 8.66x | 27.2x | 35.24x | -.--% | 14.77B | ||
| 27.52x | 13.72x | 2.31x | 4.39x | 19.99x | 20.96x | -.--% | 13.36B | ||
| 21.12x | 2.39x | 0.57x | 1.94x | 8.48x | 13.06x | 1.17% | 13.21B | ||
| -18.31x | -50.37x | -0.26x | 14.28x | -19.9x | -18.32x | -.--% | 12.23B | ||
| -33.08x | 22.02x | -2.75x | 6.26x | 154.14x | -303.4x | -.--% | 9.34B | ||
| 22.72x | 2.53x | 0.06x | 4.62x | 12.56x | 15.58x | 0.45% | 9.18B | ||
| -20.62x | 7.7x | -1.75x | 1175.7x | -17.3x | -17.1x | -.--% | 8.65B | ||
| -30.48x | 17.47x | -3.01x | 1212.46x | -32.93x | -30.57x | - | 8.49B | ||
| 42.88x | 3.88x | 0.25x | 6.83x | 19.12x | 21.05x | 0.59% | 8.43B | ||
| 16.58x | 0.88x | -0.52x | 1.39x | 7.09x | 7.89x | -.--% | 8.19B | ||
| -22.54x | 6.17x | -62.36x | 140.48x | -15.88x | -14.45x | -.--% | 6.82B | ||
| 41.64x | 2.26x | 0.22x | 6.67x | 47.46x | 65.56x | 0.78% | 6.78B | ||
| Average | 13.58x | 13.56x | -3.45x | 173.06x | 16.13x | -5.18x | 0.27% | 15.49B | |
| Weighted average by Cap. | 24.16x | 12.73x | -1.03x | 105.47x | 18.08x | 8.16x | 0.31% |
- Stock Market
- Equities
- PRTC Stock
- Sector PureTech Health plc
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
















